Timothy D Le Cras

13PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Korean language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 11, 2026
RAS Inhibitor RMC-7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells.

|Jan 07, 2026
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRASQ61R Human Endothelial Cells.

Sara Alharbi, Andrew Wagner, Svatava Merkle

|Aug 29, 2025
Human Lymphatic Endothelial Cells Expressing NRASQ61R Model Characteristics of Kaposiform Lymphangiomatosis.

Dermot A Fox, C Griffin McDaniel, Patricia Pastura

|Dec 26, 2024
Lyve1-Driven NrasQ61R Causes Edema, Enlarged Lymphatic Vessels, and Hepatic Vascular Defects in Embryonic Mice.

C Griffin McDaniel, Dermot Fox, Patricia Pastura

|May 06, 2024
NRASQ61R mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model.

Patricia Pastura, C Griffin McDaniel, Sara Alharbi

|Mar 04, 2024
How we use angiopoietin-2 in the diagnosis and management of vascular anomalies.

Elissa R Engel, Timothy D Le Cras, Kiersten W Ricci

Pageof 3

Frequent Collaborators

4 joint publications

Elisa Boscolo

4 joint publications

C Griffin McDaniel

3 joint publications

Denise M Adams

3 joint publications

Sara Alharbi